Articles with public access mandates - Robert RalstonLearn more
Not available anywhere: 1
Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa‐2b
J Vermehren, S Susser, CM Lange, N Forestier, U Karey, E Hughes, ...
Journal of viral hepatitis 19 (2), 120-127, 2012
Mandates: German Research Foundation
Available somewhere: 7
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients
S Susser, C Welsch, Y Wang, M Zettler, FS Domingues, U Karey, ...
Hepatology 50 (6), 1709-1718, 2009
Mandates: German Research Foundation
Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport
JG Smith, A Cassany, L Gerace, R Ralston, GR Nemerow
Journal of virology 82 (13), 6492-6500, 2008
Mandates: US National Institutes of Health
Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3
B Tumurbaatar, I Tikhanovich, Z Li, J Ren, R Ralston, S Kuravi, ...
The American journal of pathology 183 (6), 1803-1814, 2013
Mandates: US National Institutes of Health
Fast hepatitis C virus RNA elimination and NS5A redistribution by NS5A inhibitors studied by a multiplex assay approach
D Liu, J Ji, TP Ndongwe, E Michailidis, CM Rice, R Ralston, ...
Antimicrobial agents and chemotherapy 59 (6), 3482-3492, 2015
Mandates: US National Institutes of Health
Hepatitis C virus infection increases autophagosome stability by suppressing lysosomal fusion through an Arl8b-dependent mechanism
KN Jones-Jamtgaard, AL Wozniak, H Koga, R Ralston, SA Weinman
Journal of Biological Chemistry 294 (39), 14257-14266, 2019
Mandates: US National Institutes of Health
Visualization of positive and negative sense viral RNA for probing the mechanism of direct-acting antivirals against hepatitis C virus
D Liu, PR Tedbury, S Lan, AD Huber, MN Puray-Chavez, J Ji, ...
Viruses 11 (11), 1039, 2019
Mandates: US National Institutes of Health
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus
D Liu, TP Ndongwe, J Ji, AD Huber, E Michailidis, CM Rice, R Ralston, ...
Viruses 15 (4), 981, 2023
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program